Key result
Cx36 overexpression delays type 1 diabetes in NOD mice by preserving islet gap junction coupling.
Why the study?
It was unknown how islet gap junction coupling and Ca2+ dynamics are altered in mouse models of type 1 diabetes prior to diabetes onset.
Does modulation of Cx36 gap junction coupling and intracellular Ca2+ protect against islet decline and apoptosis in mouse models of Type 1 Diabetes?
Does modulation of Cx36 gap junction coupling and intracellular Ca2+ protect against islet decline and apoptosis in mouse models of Type 1 Diabetes?
p-value: p=0.044
Decreases in islet gap junction coupling occur prior to Type 1 Diabetes onset, altering islet susceptibility to apoptosis due to disrupted Ca2+ dynamics.
Should not yet guide clinical Type 1 diabetes care; leaves open human translation of Cx36 gap junction modulation.
In type 1 diabetes (T1D), islet dysfunction occurs prior to diabetes onset. Pro-inflammatory cytokines can disrupt insulin secretion and Ca2+ homeostasis. Connexin36 (Cx36) gap junctions electrically couple β-cells to coordinate glucose-stimulated Ca2+ and insulin secretion. Cx36 gap junction coupling can also protect against cytokine-induced apoptosis. Our goal was to determine how islet gap junction coupling and Ca2+ dynamics are altered in mouse models of T1D prior to diabetes. Glucose tolerance was assessed in NOD and immunodeficient NOD-RAG1KO mice at 6–12 weeks age. Glucose-stimulated insulin secretion, Ca2+ dynamics, and gap junction coupling were measured in islets isolated at each age. Gap junction coupling was also measured in islets from mice that underwent transfer of diabetogenic splenocytes and from chromograninA knockout NOD mice. Cell death was measured in islets isolated from wild-type, Cx36 knockout or Cx36 over-expression mice, each treated with a cocktail of pro-inflammatory cytokines and KATP or SERCA activators/inhibitors. NOD mice over-expressing Cx36 were also monitored for diabetes development, and islets assessed for insulitis and apoptosis. NOD and NOD-RAG1KO controls showed similar glucose tolerance at all ages. Ca2+ dynamics and gap junction coupling were disrupted in islets of NOD mice at 9 weeks, compared to controls. Transfer of diabetogenic splenocytes also decreased gap junction coupling. Islets from chromograninA knockout mice displayed normal coupling. Overexpression of Cx36 protected islets from cytokine-induced apoptosis. A knockout of Cx36 amplified cytokine-induced apoptosis, which was reversed by KATP activation or SERCA activation. Cx36 overexpression in NOD mice delayed diabetes development compared to NOD controls. However, apoptosis and insulitis were not improved. Decreases in islet gap junction coupling occur prior to T1D onset. Such decreases alter islet susceptibility to apoptosis due to altered Ca2+. Future studies will determine if increasing Cx36 gap junction coupling in combination with restoring Ca2+ homeostasis protects against islet decline in T1D.
No takes yet. Share an insight, caveat, or question.
Farnsworth et al. (2022) studied Type 1 Diabetes. Connexin36 (Cx36) overexpression vs. Wild-type NOD controls was evaluated on Diabetes development (p=0.044). Decreases in islet gap junction coupling occur prior to Type 1 Diabetes onset, and overexpression of Cx36 significantly delayed diabetes development in NOD mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: